Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab.

Yunoki T, Mitarai K, Yanagisawa S, Kato T, Ishida N, Hayashi A.

J Ophthalmol. 2013;2013:415974. doi: 10.1155/2013/415974. Epub 2013 Feb 20.

2.

Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab.

Yunoki T, Miyakoshi A, Nakamura T, Fujita K, Fuchizawa C, Hayashi A.

Jpn J Ophthalmol. 2012 Mar;56(2):159-64. doi: 10.1007/s10384-011-0114-3. Epub 2012 Jan 14.

PMID:
22246387
3.

25-gauge vitrectomy versus intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion: 1 year follow-up.

Sato T, Sawada K, Iwahashi-Shima C, Bando H, Ikeda T, Emi K.

Ann Acad Med Singapore. 2012 Jul;41(7):294-9.

4.

Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.

Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.

Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1.

PMID:
18327140
5.

[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].

Saleh M, Gaucher D, Letsch J, Bourcier T, Speeg-Schatz C.

J Fr Ophtalmol. 2011 Jun;34(6):355-61. doi: 10.1016/j.jfo.2011.04.008. Epub 2011 Jun 8. French.

6.

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results.

Demir M, Oba E, Gulkilik G, Odabasi M, Ozdal E.

Clin Ophthalmol. 2011;5:745-9. doi: 10.2147/OPTH.S19279. Epub 2011 Jun 3.

7.

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results.

Thapa R, Maharjan N, Paudyal G.

Clin Ophthalmol. 2012;6:1057-62. doi: 10.2147/OPTH.S30555. Epub 2012 Jul 12.

8.

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion.

Ogino K, Tsujikawa A, Murakami T, Muraoka Y, Kurashige Y, Yoshimura N.

Clin Ophthalmol. 2011;5:1031-6. doi: 10.2147/OPTH.S22923. Epub 2011 Jul 26.

9.

Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.

Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G.

Acta Ophthalmol. 2012 Jun;90(4):357-61. doi: 10.1111/j.1755-3768.2010.01913.x. Epub 2010 Jun 29.

10.

Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion.

Tsujikawa A, Fujihara M, Iwawaki T, Yamamoto K, Kurimoto Y.

Retina. 2005 Oct-Nov;25(7):861-7.

PMID:
16205565
11.

Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion.

Raszewska-Steglinska M, Gozdek P, Cisiecki S, Michalewska Z, Michalewski J, Nawrocki J.

Eur J Ophthalmol. 2009 Nov-Dec;19(6):1055-62.

PMID:
19882567
12.

Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion.

Noma H, Shimada K, Mimura T.

Int Ophthalmol. 2013 Dec;33(6):677-86. doi: 10.1007/s10792-013-9762-2. Epub 2013 Mar 29.

PMID:
23539479
13.

Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion.

Noma H, Shimada K, Mimura T.

Int Ophthalmol. 2013 Jun;33(3):227-36. doi: 10.1007/s10792-012-9676-4. Epub 2012 Nov 19.

PMID:
23160823
14.

Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema.

Shimura M, Nakazawa T, Yasuda K, Kunikata H, Shiono T, Nishida K.

Acta Ophthalmol. 2008 Jun;86(4):377-84. Epub 2007 Nov 26.

15.

Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.

Riese J, Loukopoulos V, Meier C, Timmermann M, Gerding H.

Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1671-6. doi: 10.1007/s00417-008-0898-0. Epub 2008 Aug 16.

PMID:
18709384
16.

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion.

Gokce G, Sobaci G, Durukan AH, Erdurman FC.

Clin Ophthalmol. 2014 Feb 7;8:355-62. doi: 10.2147/OPTH.S58468. eCollection 2014.

17.

Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.

Doi N, Sakamoto T, Sonoda Y, Yasuda M, Yonemoto K, Arimura N, Uchino E, Ishibashi T.

Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):71-8. doi: 10.1007/s00417-011-1777-7. Epub 2011 Aug 19.

PMID:
21853229
18.

Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion.

Baharivand N, Hariri A, Javadzadeh A, Heidari E, Sadegi K.

Clin Ophthalmol. 2011;5:1089-93. doi: 10.2147/OPTH.S23164. Epub 2011 Aug 5.

19.

Transient increase in macular edema following vitrectomy for retinal branch vein occlusion.

Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y.

Int Ophthalmol. 2009 Apr;29(2):95-8. Epub 2007 Nov 16.

PMID:
18008053
20.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

CekiƧ O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
Items per page

Supplemental Content

Write to the Help Desk